Small Molecule Binding to Alzheimer Risk Factor CD33 Promotes Aβ Phagocytosis

IScience
Luke A MilesMichael W Parker

Abstract

Polymorphism in the microglial receptor CD33 gene has been linked to late-onset Alzheimer disease (AD), and reduced expression of the CD33 sialic acid-binding domain confers protection. Thus, CD33 inhibition might be an effective therapy against disease progression. Progress toward discovery of selective CD33 inhibitors has been hampered by the absence of an atomic resolution structure. We report here the crystal structures of CD33 alone and bound to a subtype-selective sialic acid mimetic called P22 and use them to identify key binding residues by site-directed mutagenesis and binding assays to reveal the molecular basis for its selectivity toward sialylated glycoproteins and glycolipids. We show that P22, when presented on microparticles, increases uptake of the toxic AD peptide, amyloid-β (Aβ), into microglial cells. Thus, the sialic acid-binding site on CD33 is a promising pharmacophore for developing therapeutics that promote clearance of the Aβ peptide that is thought to cause AD.

Citations

Jun 26, 2020·Expert Opinion on Biological Therapy·Roland B Walter
Jul 14, 2020·Expert Opinion on Investigational Drugs·Bruno P ImbimboFrancesco Panza
Dec 6, 2019·Frontiers in Neuroscience·Yuanyuan LiuMomiao Xiong
Aug 7, 2020·Organic & Biomolecular Chemistry·Levon D Movsisyan, Matthew S Macauley
Jun 25, 2020·International Journal of Molecular Sciences·Przemyslaw WielgatHalina Car
Oct 11, 2020·Nature Communications·Emily RodriguesMatthew S Macauley
Oct 20, 2020·Frontiers in Neurology·Kendra L Hanslik, Tyler K Ulland
Sep 2, 2020·Annual Review of Medicine·William J Ray, Virginie Buggia-Prevot
Feb 15, 2021·Neuroscience Letters·Vasileios SiokasEfthimios Dardiotis
Feb 2, 2021·Frontiers in Neuroscience·Henriette Haukedal, Kristine K Freude
Nov 18, 2020·Genes·Vasileios SiokasEfthimios Dardiotis
Feb 10, 2021·Current Opinion in Neurology·Ana Griciuc, Rudolph E Tanzi
Mar 23, 2021·Frontiers in Molecular Neuroscience·Nicholas Peoples, Candace Strang
Apr 25, 2021·Proceedings of the National Academy of Sciences of the United States of America·Christian BüllYoshiki Narimatsu
Apr 20, 2021·Frontiers in Neuroscience·Punam Rawal, Liqin Zhao
Jun 3, 2021·Biomedicines·Isaac G OnyangoGorazd B Stokin
Jun 3, 2021·Cells·Anabel Gonzalez-Gil, Ronald L Schnaar
Aug 16, 2021·Ageing Research Reviews·Zoë P Van AckerWim Annaert

❮ Previous
Next ❯

Methods Mentioned

BETA
X-ray
flow cytometry
surface plasmon resonance
Competition

Related Concepts

Related Feeds

Alzheimer's Disease: Microglia

Microglia are a type of glial cell found throughout the brain and spinal cord. Microglia have been found to be associated with Alzheimer's disease development and progression. Here are the latest discoveries pertaining to Alzheimer's disease and microglia.